Sign In
Buy LH
$309.20
-6.33 (-2.01%)
At Close: Jul 31, 2026
Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw BURLINGTON, N.C. , Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH),
Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'
02:12pm, Thursday, 13'th Feb 2025
Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitiv
Why Labcorp (LH) is a Top Momentum Stock for the Long-Term
10:51am, Wednesday, 12'th Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Investors Undervaluing Labcorp (LH) Right Now?
10:46am, Tuesday, 11'th Feb 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Here's Why Labcorp (LH) is a Strong Growth Stock
10:46am, Tuesday, 11'th Feb 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Labcorp (LH) is a Top Value Stock for the Long-Term
10:40am, Monday, 10'th Feb 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript
03:42pm, Thursday, 06'th Feb 2025
Labcorp Holdings Inc. (NYSE:LH ) Q4 2024 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Christian O'Donnell - IR Adam Schechter - Chairman and CEO Julia Wang - EVP and CFO C
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
01:22pm, Thursday, 06'th Feb 2025
Thursday, Laboratory Corp (NYSE: LH) reported fourth-quarter 2024 adjusted earnings per share of $3.45, up from $3.30 a year ago, beating the consensus of $3.39.
Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics
10:36am, Thursday, 06'th Feb 2025
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street
Labcorp Q4 Earnings & Revenues Beat, Margins Down, Stock Tumbles
10:21am, Thursday, 06'th Feb 2025
LH delivers better-than-expected revenues and earnings in the fourth quarter of 2024.
Labcorp (LH) Q4 Earnings and Revenues Surpass Estimates
09:01am, Thursday, 06'th Feb 2025
Labcorp (LH) came out with quarterly earnings of $3.45 per share, beating the Zacks Consensus Estimate of $3.40 per share. This compares to earnings of $3.30 per share a year ago.
Labcorp forecasts 2025 revenue above estimates on diagnostic test demand
06:55am, Thursday, 06'th Feb 2025
Labcorp forecast 2025 revenue above Wall Street estimates after reporting fourth-quarter results beat on Thursday, banking on robust demand for its diagnostic tests.
Labcorp Announces 2024 Fourth Quarter and Full Year Results
06:50am, Thursday, 06'th Feb 2025
Company Provides 2025 Guidance Results from Continuing Operations versus last year: Revenue: Q4 of $3.33 billion vs $3.03 billion; Full year of $13.01 billion vs $12.16 billion Diluted EPS: Q4 of $1.7
Labcorp (LH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Tuesday, 04'th Feb 2025
Beyond analysts' top -and-bottom-line estimates for Labcorp (LH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
Labcorp Set to Report Q4 Earnings: What's in Store for the Stock?
10:06am, Friday, 31'st Jan 2025
In the fourth quarter of 2024, LH is likely to have witnessed strong growth in both diagnostics and biopharma laboratory services.
